Safety and appropriate use of salmeterol in the treatment of asthma. AAAAI Committee on Drugs, American Academy of Allergy, Asthma and Immunology.
D000318:Adrenergic beta-Agonists / Q000494:pharmacology* / Q000592:standards*; D000420:Albuterol / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000592:standards; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000494:pharmacology / Q000592:standards; D006801:Humans; D000068299:Salmeterol Xinafoate; D012955:Societies, Medical; D014481:United States
D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D000068299:Salmeterol Xinafoate; D000420:Albuterol